Activation of Platinum(IV) Prodrugs by Cytochrome c and Characterization of the Protein Binding Sites

0470807 - BFÚ 2017 RIV US eng J - Článek v odborném periodiku
Lasorsa, A. - Stuchlíková, O. - Brabec, Viktor - Natile, G. - Arnesano, F.
Activation of Platinum(IV) Prodrugs by Cytochrome c and Characterization of the Protein Binding Sites.
Molecular Pharmaceutics. Roč. 13, č. 9 (2016), s. 3216-3223. ISSN 1543-8384. E-ISSN 1543-8392
Institucionální podpora: RVO:68081707
Klíčová slova: mass-spectrometry * reduction products * antitumor agents
Kód oboru RIV: BO - Biofyzika
Impakt faktor: 4.440, rok: 2016

Platinum(IV) complexes generally require reduction to reactive Pt(II) species to exert their chemotherapeutic activity. The process of reductive activation of N-15-labeled (OC-6-43)-bis(acetato)diamminedichloridoplatinum-(IV), in the presence of nicotinamide adenine dinucleotide (NADH) and horse heart cytochrome c (cyt c), was monitored by H-1,N-15-HSQC NMR spectroscopy and protein digestion experiments. It has been shown that cyt c plays a catalytic role in the transfer of two reducing equivalents from NADH to Pt(IV) species. Noncovalent interactions between reduced monoaqua cisplatin (cis-[PtCl((NH3)-N-15)(2)(H2O)](+)) and the protein, in the proximity of the heme cofactor, and also covalent binding of platinum to the protein region around Met65 and Met80 take place.
Trvalý link: http://hdl.handle.net/11104/0269076